Come together with leaders from the pharmaceutical, biotechnology and diagnostic industries to unpack huge changes this May.
In a year of major change and outstanding questions, growing scrutiny on patent protection and drug pricing, and uncertainty around global price control measures and the Inflation Reduction Act, understanding the implications of new leadership and emerging mandates is critical.
Gain insights from leading in-house counsel, patent prosecutors, litigators, and the USPTO. Explore strategies to maximize patent terms, navigate the Unified Patent Court, and address key prosecution challenges. Benchmark with peers and stay ahead in the evolving life sciences IP landscape.
Conference Co-Chairs
Anne Elise Herold Li
Partner
Crowell & Moring LLP
Jasbir K. Sagoo, Ph.D., J.D.
Associate Vice President of Intellectual Property
Agilent Technologies
CLE Accreditation
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as non-transitional for the purposes of CLE accreditation.
Learn more“This event not to be missed!”
“Good mix of in-house, private practice, and government.”
“Very enjoyable – wonderful speakers that are well qualified – great content.”
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]
